Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Apr 28;20(6):352. doi: 10.1038/s41577-020-0324-3

Does asthma make COVID-19 worse?

Samarth Hegde 1,
PMCID: PMC7186942  PMID: 32346090

There is active interest in reconciling the tremendous variation observed in COVID-19 outcomes with host immunity. In this preprint, Sajuthi et al. analyse nasal airway epithelial transcriptomes from a large cohort of healthy and asthmatic subjects to distinguish relative contributions of host immune networks to coronavirus susceptibility. They use network co-expression analyses and transcriptomics on mucociliary cultures to show that genes implicated in SARS-CoV-2 infectivity, specifically TMPRSS2 and ACE2, are significantly influenced by type 2 cytokine-driven inflammation and interferon signalling, respectively. Although SARS-CoV-2-specific analysis and experiments are lacking, the study provides a rationale for why type 2 responses, which are aggravated in patients with asthma, might increase susceptibility to severe COVID-19.

Competing interests

The author declares no competing interests.

References

Original article

  1. Sajuthi SP, et al. Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium. bioRxiv. 2020 doi: 10.1101/2020.04.09.034454. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nature Reviews. Immunology are provided here courtesy of Nature Publishing Group

RESOURCES